A comprehensive view of Combination Therapy. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to REGENERON PHARMACEUTICALS on April 23 for "Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy" (New York Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Bristol-Myers Squibb, Celldex Therapeutics on April 23 for "Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment" (Pennsylvania, Maryland, Connecticut Inventors)
Published: April 24, 2024 by U.S. Fed News
Study shows that withdrawing aspirin and keeping high-risk heart patients on ticagrelor a month after a percutaneous coronary intervention improves outcomes and reduces bleeding by over half; the findings may change worldwide standard of care guidelines
Published: April 23, 2024 by Insurance Daily News
AstraZeneca Files United States Patent Application for Amino-Triazolopyridine Compounds and Their Use in Treating Cancer
Published: April 22, 2024 by Pharmaceutical Patent News
U.S. Patent and Trademark Office Releases Pfizer Inc's Patent Application for Pyrido[2,3-D]Imidazole Derivatives and Their Use as Inhibitors of ITK for the Treatment of Skin Disease
Published: April 22, 2024 by Pharmaceutical Patent News

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count